Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FYQJW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,693
Award facts
- Contract value 100% obligated
- $3,693.21 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,693.21 to AmerisourceBergen Drug Corp for REPATHA 140 mg/mL SureClick auto-injectors, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. REPATHA (evolocumab) is a PCSK9 inhibitor indicated for cholesterol management in eligible military beneficiaries and represents a specialized pharmaceutical product within the Defense Health Agency's medical supply portfolio.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As the prime contractor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen serves as a critical vendor for military healthcare systems worldwide, supplying specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The company's position as a major pharmaceutical distributor and healthcare solutions provider makes it a key supplier supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems through flexible contract mechanisms designed to meet dynamic medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FYQJW?
SPE2DB25FYQJW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 10, 2025.
How much is contract SPE2DB25FYQJW worth?
The government has obligated $3,693 on SPE2DB25FYQJW.
Is contract SPE2DB25FYQJW an order under another contract?
Yes. SPE2DB25FYQJW is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FYQJW competed?
The extent of competition for SPE2DB25FYQJW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award